Multicystic renal dysplasia, bilateral

Active Research Protocols

  1. 09-C-0005 – Randomized Trial of Cladribine (CdA) with Simultaneous or Delayed Rituximab to Eliminate Hairy Cell Leukemia Minimal Residual Disease
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014